Perkins M C, Canfield P, Churcher R K, Malik R
University Veterinary Centre Sydney, Faculty of Veterinary Science, The University of Sydney, New South Wales 2006.
Aust Vet J. 2004 Jan-Feb;82(1-2):52-7. doi: 10.1111/j.1751-0813.2004.tb14641.x.
Five cases of suspected immune-mediated neutropenia in dogs are described. Clinical signs varied depending on whether the animals had a systemic infection or concurrent immune-mediated disease. Patients were diagnosed by excluding other causes of neutropenia, supportive bone marrow aspirate findings, an initial favourable response to corticosteroid administration in four of the cases, and concurrent immune-mediated disease. Four of the dogs were receiving medications at the time of diagnosis, and immune-mediated neutropenia secondary to drug therapy cannot be excluded. This study shows that appropriate immunosuppressive treatment can lead to a favourable outcome, however, care is required to avoid adverse effects associated with corticosteroid use. It is also imperative that medications are not withdrawn abruptly as a second remission may not always be achievable.
本文描述了5例疑似犬免疫介导性中性粒细胞减少症的病例。临床症状因动物是否患有全身感染或并发免疫介导性疾病而异。通过排除中性粒细胞减少症的其他病因、支持性骨髓穿刺结果、4例病例对皮质类固醇给药的初始良好反应以及并发免疫介导性疾病来诊断患者。4只狗在诊断时正在接受药物治疗,不能排除药物治疗继发的免疫介导性中性粒细胞减少症。本研究表明,适当的免疫抑制治疗可带来良好的结果,然而,需要注意避免与使用皮质类固醇相关的不良反应。同样重要的是,药物不能突然停药,因为可能无法总是实现第二次缓解。